BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37929819)

  • 1.
    Sarkar S; DAS A
    J Biosci; 2023; 48():. PubMed ID: 37929819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling neurodegenerative and neurodevelopmental disorders in the
    Stahl A; Tomchik SM
    Learn Mem; 2024 May; 31(5):. PubMed ID: 38876485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Fly-ing' from rare to common neurodegenerative disease mechanisms.
    Ma M; Moulton MJ; Lu S; Bellen HJ
    Trends Genet; 2022 Sep; 38(9):972-984. PubMed ID: 35484057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer's disease.
    Sivanantharajah L; Mudher A; Shepherd D
    J Neurosci Methods; 2019 May; 319():77-88. PubMed ID: 30633936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and molecular studies of olfaction in Drosophila.
    Hekmat-Scafe DS; Carlson JR
    Ciba Found Symp; 1996; 200():285-96; discussion 296-301. PubMed ID: 8894304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila models of human neurodegenerative disease.
    Chan HY; Bonini NM
    Cell Death Differ; 2000 Nov; 7(11):1075-80. PubMed ID: 11139281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired sense of smell in a Drosophila Parkinson's model.
    Poddighe S; Bhat KM; Setzu MD; Solla P; Angioy AM; Marotta R; Ruffilli R; Marrosu F; Liscia A
    PLoS One; 2013; 8(8):e73156. PubMed ID: 24009736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic architecture of olfactory behavior in Drosophila melanogaster: differences and similarities across development.
    Lavagnino NJ; Arya GH; Korovaichuk A; Fanara JJ
    Behav Genet; 2013 Jul; 43(4):348-59. PubMed ID: 23563598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Drosophila melanogaster as Genetic Model System to Dissect the Mechanisms of Disease that Lead to Neurodegeneration in Adrenoleukodystrophy.
    Bülow MH; Parsons BD; Di Cara F
    Adv Exp Med Biol; 2020; 1299():145-159. PubMed ID: 33417213
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Benton R
    Proc Biol Sci; 2022 Dec; 289(1989):20222054. PubMed ID: 36515118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural Effects and RNA-seq Analysis of Aβ42-Mediated Toxicity in a Drosophila Alzheimer's Disease Model.
    Tan FHP; Azzam G; Najimudin N; Shamsuddin S; Zainuddin A
    Mol Neurobiol; 2023 Aug; 60(8):4716-4730. PubMed ID: 37145377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the efficient natural products for Alzheimer's disease therapy via
    Wu M; Li Y; Miao Y; Qiao H; Wang Y
    J Drug Target; 2023 Sep; 31(8):817-831. PubMed ID: 37545435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila as a screening tool to study human neurodegenerative diseases.
    Lenz S; Karsten P; Schulz JB; Voigt A
    J Neurochem; 2013 Nov; 127(4):453-60. PubMed ID: 24028575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drosophila melanogaster as a model organism of brain diseases.
    Jeibmann A; Paulus W
    Int J Mol Sci; 2009 Feb; 10(2):407-440. PubMed ID: 19333415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Lateral Inhibition Impairs Olfactory Computations and Behaviors in a Drosophila Model of Fragile X Syndrome.
    Franco LM; Okray Z; Linneweber GA; Hassan BA; Yaksi E
    Curr Biol; 2017 Apr; 27(8):1111-1123. PubMed ID: 28366741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Neurodegenerative Disorders in
    Bolus H; Crocker K; Boekhoff-Falk G; Chtarbanova S
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357532
    [No Abstract]   [Full Text] [Related]  

  • 17. Using Drosophila as a tool to identify pharmacological therapies for fragile X syndrome.
    McBride SM; Holloway SL; Jongens TA
    Drug Discov Today Technol; 2013; 10(1):e129-36. PubMed ID: 24050241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.